JP4559683B2 - Echinaceaサプリメントおよびその製造方法 - Google Patents

Echinaceaサプリメントおよびその製造方法 Download PDF

Info

Publication number
JP4559683B2
JP4559683B2 JP2001526187A JP2001526187A JP4559683B2 JP 4559683 B2 JP4559683 B2 JP 4559683B2 JP 2001526187 A JP2001526187 A JP 2001526187A JP 2001526187 A JP2001526187 A JP 2001526187A JP 4559683 B2 JP4559683 B2 JP 4559683B2
Authority
JP
Japan
Prior art keywords
echinacea
acid
present
alkylamide
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001526187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003510285A5 (enExample
JP2003510285A (ja
Inventor
ローランド ジェイ. ガーラー,
リチャード イー. バートン,
ジァン ブイ. スラマ,
チャック シー. チャン,
Original Assignee
ファクターズ アール アンド ディー テクノロジーズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファクターズ アール アンド ディー テクノロジーズ リミテッド filed Critical ファクターズ アール アンド ディー テクノロジーズ リミテッド
Publication of JP2003510285A publication Critical patent/JP2003510285A/ja
Publication of JP2003510285A5 publication Critical patent/JP2003510285A5/ja
Application granted granted Critical
Publication of JP4559683B2 publication Critical patent/JP4559683B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2001526187A 1999-09-30 2000-08-11 Echinaceaサプリメントおよびその製造方法 Expired - Fee Related JP4559683B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15719499P 1999-09-30 1999-09-30
US60/157,194 1999-09-30
PCT/CA2000/000931 WO2001022977A2 (en) 1999-09-30 2000-08-11 Echinacea supplement and method of manufacture

Publications (3)

Publication Number Publication Date
JP2003510285A JP2003510285A (ja) 2003-03-18
JP2003510285A5 JP2003510285A5 (enExample) 2005-09-29
JP4559683B2 true JP4559683B2 (ja) 2010-10-13

Family

ID=22562708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001526187A Expired - Fee Related JP4559683B2 (ja) 1999-09-30 2000-08-11 Echinaceaサプリメントおよびその製造方法

Country Status (14)

Country Link
US (2) US6511683B1 (enExample)
EP (1) EP1220680B1 (enExample)
JP (1) JP4559683B2 (enExample)
CN (1) CN1240403C (enExample)
AT (1) ATE388718T1 (enExample)
AU (1) AU777453B2 (enExample)
CA (1) CA2379581C (enExample)
DE (1) DE60038308T2 (enExample)
DK (1) DK1220680T3 (enExample)
ES (1) ES2303512T3 (enExample)
HK (1) HK1048943B (enExample)
NZ (1) NZ517371A (enExample)
PT (1) PT1220680E (enExample)
WO (1) WO2001022977A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2407712A1 (en) * 2000-05-05 2001-11-15 Bioniche Life Sciences Inc. Use of echinacea as a hematinic agent
US6746697B2 (en) * 2000-12-15 2004-06-08 Phytos, Inc. Composition containing Heliopsis longipes root extract and oral carrier
EP1297751A1 (de) * 2001-10-01 2003-04-02 Bogar AG Oral zu verabreichende Zubereitung
NZ515182A (en) * 2001-10-31 2004-03-26 Brightwater Horticulture Ltd Extraction of biologically active compounds from plant material using acid and antioxidant
ITMI20021692A1 (it) * 2002-07-30 2002-10-29 Indena Spa Polisaccaride di echinacea angustifolia.
ITMI20021691A1 (it) * 2002-07-30 2004-01-30 Indena Spa Estratti di echinacea angustifolia
CA2522088A1 (en) * 2003-04-16 2004-11-04 The University Of Mississippi Immunostimulatory agents in botanicals
CN1297568C (zh) * 2003-08-08 2007-01-31 吉林威威药业股份有限公司 一种松果菊多糖、其制备方法及其在制备治疗抗病毒、抗菌及抗sars药物上的用途
US20050175721A1 (en) * 2004-02-06 2005-08-11 Brovelli Ernesto A. Method of augmenting the immune-modulatory activity of standardized Echinacea preparations
US8003136B2 (en) * 2004-03-03 2011-08-23 Randy Beavers Standardization of botanical products utilizing biological activity as a marker
AU2005259854C1 (en) * 2004-07-07 2011-06-02 Integria Healthcare (Australia) PTY LTD An Echinacea formulation
GB2432788C (en) * 2004-07-07 2018-06-27 Integria Healthcare Australia Pty Ltd An echinacea formulation
US8062686B2 (en) * 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
US7491414B2 (en) * 2005-10-12 2009-02-17 Gaia Herbs, Inc. Anti-inflammatory substances extracted from Echinacea
US7829098B2 (en) * 2005-11-08 2010-11-09 Vita Green Health Products Co., Ltd Herbal powder extracts and methods of preparing and using the same
CA2632607A1 (en) * 2005-12-09 2007-06-21 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
CN101032541B (zh) * 2006-07-28 2011-05-11 成都地奥九泓制药厂 一种紫锥菊提取物及其制备方法和含量测定方法
CH699653B1 (de) * 2008-09-08 2010-05-14 Bioforce Ag Roggwil Tg Zubereitung zur Prävention und/oder Behandlung und/oder Verhinderung der Weiterverbreitung von Atemwegserkrankungen.
US8273385B1 (en) 2008-10-17 2012-09-25 Thres Flo, LLC Oral rinse composition and method
EP2766009B1 (en) * 2011-10-11 2019-10-09 ELC Management LLC Method and compositions for treating skin
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
KR102440040B1 (ko) * 2013-03-14 2022-09-02 마리 케이 인코포레이티드 화장품 조성물들
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
DE102017206827A1 (de) 2017-04-24 2018-10-25 Roman Gehre Gewinnung und Nutzung von Polyphenolen, insbesondere Cichoriensäure, aus Pflanzen der Gattung Posidonia
JP7488573B2 (ja) * 2021-01-14 2024-05-22 株式会社山田養蜂場本社 マクロファージ活性剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0213099A3 (de) * 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
DE3744570A1 (de) * 1987-12-30 1989-07-13 Lohmann Rudolf Lomapharm Pharmazeutische zubereitungen mit immunstimulierender wirkung und verfahren zu ihrer herstellung
DE3744571A1 (de) * 1987-12-30 1989-07-13 Lohmann Rudolf Lomapharm Pharmazeutische zubereitungen zur stimulierung des immunsystems und verfahren zu ihrer herstellung
CH676931A5 (en) * 1988-08-02 1991-03-28 Spagyros S A Herbal medicaments prodn. - contg. essential antimicrobial oils and Echinacea tinctures, for treating infections, etc.
EP0464298B1 (en) * 1990-07-05 1995-06-21 INDENA S.p.A. Echinacea extracts, a process for the preparation thereof and formulations containing them
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US5455033A (en) * 1993-05-21 1995-10-03 Degree/Silverman M.D. Inc. Medicinal composition for treatment of inflammation
FR2742987B1 (fr) * 1996-01-03 1998-04-03 Lvmh Rech Utilisation dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie, d'un extrait d'eriobotrya japonica pour stimuler la synthese des glycosaminoglycanes
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
CA2307614A1 (en) * 1997-10-23 1999-04-29 Elliot P. Friedman Pharmaceutical grade echinacea
US6217878B1 (en) * 1999-08-13 2001-04-17 Amway Corporation Method of preparing echinacea powder

Also Published As

Publication number Publication date
US6511683B1 (en) 2003-01-28
CN1240403C (zh) 2006-02-08
WO2001022977A3 (en) 2001-12-06
CA2379581A1 (en) 2001-04-05
HK1048943A1 (en) 2003-04-25
AU6674300A (en) 2001-04-30
EP1220680A2 (en) 2002-07-10
CA2379581C (en) 2011-03-22
CN1376068A (zh) 2002-10-23
AU777453B2 (en) 2004-10-14
HK1048943B (zh) 2006-09-01
DE60038308T2 (de) 2009-03-12
NZ517371A (en) 2004-03-26
PT1220680E (pt) 2008-06-25
DE60038308D1 (de) 2008-04-24
EP1220680B1 (en) 2008-03-12
WO2001022977A2 (en) 2001-04-05
JP2003510285A (ja) 2003-03-18
ES2303512T3 (es) 2008-08-16
DK1220680T3 (da) 2008-07-14
ATE388718T1 (de) 2008-03-15
US20030152653A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
JP4559683B2 (ja) Echinaceaサプリメントおよびその製造方法
ES2625848T3 (es) Ingredientes activos de matricaria (tanacetum parthenium) libres de partenolida y proceso para su producción
Dumacheva Biological resources of the Hyssopus l on the south of European Russia and prospects of its introduction
KR20170055758A (ko) 식물 추출물을 포함하는 염증 개선용 조성물
Kanoma et al. Qualitative and quantitative phytochemical screening of cola nuts (Cola nitida and Cola acuminata)
TWI323641B (en) Tissues with rich flavonoids of neomarica gracilis and belamcanda chinensis and culture methods for the same
US10716822B2 (en) Seed of new soybean cultivar SCEL-1, plant body of the seed and part of the plant body, and extract obtained from the seed
ES2401390T3 (es) Proceso de preparación de una fracción anti-microbiana a partir de Juglans regia
KR20160058201A (ko) 발효 미생물을 이용한 수경재배 인삼 잎 분말의 제조 방법 및 이에 따라 제조된 수경재배 인삼 잎 분말
Nikolic et al. Assaying the variation in secondary metabolites of St. John’s wort for its better use as an antibiotic
US11426421B2 (en) Composition for preventing or improving inflammation including extract of seed of new soybean cultivar SCEL-1
Singh et al. Medicinal Solanum Species: A Short Review
CN101637300A (zh) 强化全元素复合肥于烟叶的富硒防癌香烟
Solunke et al. Development of a high-performance liquid chromatography (HPLC) method for analysis of charantin in bitter gourd (Momordica charantia) fruits
Mbembo et al. Natural Resources for Human Health
AU2013201510A1 (en) Parthenolide Free Bioactive Ingredients from Feverfew (Tanacetum Parthenium) and Processes for their Production
Khomich et al. Wild berries in Ukraine
JP2005320307A (ja) 新規セスキテルペン系化合物、その製造方法及び組成物
JP2012025689A (ja) 抗腫瘍剤及び機能改善剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071022

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090331

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090629

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090706

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090730

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100715

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100723

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130730

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees